183 related articles for article (PubMed ID: 34355667)
1.
Chaudhary M; Sehgal D
J Biomol Struct Dyn; 2022; 40(22):11560-11570. PubMed ID: 34355667
[TBL] [Abstract][Full Text] [Related]
2. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus.
Patil P; Agrawal M; Almelkar S; Jeengar MK; More A; Alagarasu K; Kumar NV; Mainkar PS; Parashar D; Cherian S
Virol J; 2021 Feb; 18(1):47. PubMed ID: 33639977
[TBL] [Abstract][Full Text] [Related]
4. In silico identification of chikungunya virus replication inhibitor validated using biochemical and cell-based approaches.
Chaudhary M; Kumar A; Bala Sharma K; Vrati S; Sehgal D
FEBS J; 2024 Feb; ():. PubMed ID: 38303163
[TBL] [Abstract][Full Text] [Related]
5. Development of a theoretical model for the inhibition of nsP3 protease of Chikungunya virus using pyranooxazoles.
Kumar D; Kumari K; Jayaraj A; Singh P
J Biomol Struct Dyn; 2020 Jul; 38(10):3018-3034. PubMed ID: 31366291
[TBL] [Abstract][Full Text] [Related]
6. Is the ADP ribose site of the Chikungunya virus NSP3 Macro domain a target for antiviral approaches?
Shimizu JF; Martins DOS; McPhillie MJ; Roberts GC; Zothner C; Merits A; Harris M; Jardim ACG
Acta Trop; 2020 Jul; 207():105490. PubMed ID: 32333884
[TBL] [Abstract][Full Text] [Related]
7.
Chandra A; Chaudhary M; Qamar I; Singh N; Nain V
J Biomol Struct Dyn; 2022 Sep; 40(14):6534-6544. PubMed ID: 33583328
[TBL] [Abstract][Full Text] [Related]
8. Host Factor Nucleophosmin 1 (NPM1/B23) Exerts Antiviral Effects against Chikungunya Virus by Its Interaction with Viral Nonstructural Protein 3.
Pradeep P; Sivakumar KC; Sreekumar E
Microbiol Spectr; 2023 Aug; 11(4):e0537122. PubMed ID: 37409962
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-Chikungunya virus activity of lomerizine derivatives.
Chen CR; Ma Y; Wang HX; Liu XY; Liu Y; Meng QG; Jin YS
Bioorg Med Chem Lett; 2023 Mar; 83():129188. PubMed ID: 36804408
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing approach against chikungunya virus: an
Kasabe B; Ahire G; Patil P; Punekar M; Davuluri KS; Kakade M; Alagarasu K; Parashar D; Cherian S
Front Cell Infect Microbiol; 2023; 13():1132538. PubMed ID: 37180434
[TBL] [Abstract][Full Text] [Related]
12. Discovery of small molecule inhibitors of chikungunya virus proteins (nsP2 and E1) using
Khan N; Bhat R; Patel AK; Ray P
J Biomol Struct Dyn; 2021 Mar; 39(4):1373-1385. PubMed ID: 32072865
[TBL] [Abstract][Full Text] [Related]
13. In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.
Dutta SK; Sengupta S; Tripathi A
In Vitro Cell Dev Biol Anim; 2022 Mar; 58(3):255-267. PubMed ID: 35381943
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Antiviral Potential of Halogenated Dihydrorugosaflavonoids and Molecular Modeling with nsP3 Protein of Chikungunya Virus (CHIKV).
Puranik NV; Rani R; Singh VA; Tomar S; Puntambekar HM; Srivastava P
ACS Omega; 2019 Dec; 4(23):20335-20345. PubMed ID: 31815237
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
[TBL] [Abstract][Full Text] [Related]
16. Designed thiazolidines: an arsenal for the inhibition of nsP3 of CHIKV using molecular docking and MD simulations.
Meena MK; Kumar D; Jayaraj A; Kumar A; Kumari K; Katata-Seru LM; Bahadur I; Kumar V; Sherawat A; Singh P
J Biomol Struct Dyn; 2022 Mar; 40(4):1607-1616. PubMed ID: 33073705
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Inhibitor Binding Combined with Reactivity Studies to Discover the Potentially Inhibiting Phytochemicals Targeting Chikungunya Viral Replication.
Rasool N; Bakht A; Hussain W
Curr Drug Discov Technol; 2021; 18(3):437-450. PubMed ID: 32164512
[TBL] [Abstract][Full Text] [Related]
18. Ethyl palmitate, an anti-chikungunya virus principle from Sauropus androgynus, a medicinal plant used to alleviate fever in ethnomedicine.
Sagna A; Nair RVR; Hulyalkar N; Rajasekharan S; Nair VTG; Sivakumar KC; Suja SR; Baby S; Sreekumar E
J Ethnopharmacol; 2023 Jun; 309():116366. PubMed ID: 36914036
[TBL] [Abstract][Full Text] [Related]
19. Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors.
Ahmed SK; Haese NN; Cowan JT; Pathak V; Moukha-Chafiq O; Smith VJ; Rodzinak KJ; Ahmad F; Zhang S; Bonin KM; Streblow AD; Streblow CE; Kreklywich CN; Morrison C; Sarkar S; Moorman N; Sander W; Allen R; DeFilippis V; Tekwani BL; Wu M; Hirsch AJ; Smith JL; Tower NA; Rasmussen L; Bostwick R; Maddry JA; Ananthan S; Gerdes JM; Augelli-Szafran CE; Suto MJ; Morrison TE; Heise MT; Streblow DN; Pathak AK
J Med Chem; 2021 Apr; 64(8):4762-4786. PubMed ID: 33835811
[TBL] [Abstract][Full Text] [Related]
20. Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4.
Martins DOS; Souza RAC; Freire MCLC; de Moraes Roso Mesquita NC; Santos IA; de Oliveira DM; Junior NN; de Paiva REF; Harris M; Oliveira CG; Oliva G; Jardim ACG
J Biol Inorg Chem; 2023 Feb; 28(1):101-115. PubMed ID: 36484824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
